RNA logo

Avidity Biosciences, Inc. (RNA)

Profile

Full Name

Avidity Biosciences, Inc.

Ticker

NASDAQ: RNA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 12, 2020

Indexes

Not included

Website

http://www.aviditybiosciences.com

Employees

391

Key Details

Price

$36.27(+9.21%)

Market cap

$4.37B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$10.90M(+13.99% YoY)

Annual EPS

-$2.89(+0.69% YoY)

PE ratio

-

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $36.27
    RNA price is $36.27

    30-Day Relative Volume

    3.01
    RNA 30-day relative volume is 3.01

    Price Performance

    Price Most recent change

    +9.21%
    RNA price was up +9.21% on Jul 25, 2025

    Price YTD change

    +24.72%
    RNA price is up +24.72% since January 1st

    Price 1-year change

    -18.9%
    RNA price is down -18.9% year-on-year

    Price 3-year change

    +116.02%
    RNA price is up +116.02% over the past 3 years

    Price Range

    Price All-time high

    $56.00
    RNA price is currently -35.23% below its historical high of $56.00

    Price 3-year low

    $4.83
    RNA price is currently +651.71% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $4.37B
    RNA market capitalization is $4.37 billion

    Market cap 3-year change

    +399.45%
    RNA market capitalization is up +399.45% over the past 3 years

    Market cap All-time high

    $6.27B
    RNA market capitalization is currently -30.29% below its historical high of $6.27 billion

    Market cap sector rank

    88.29%
    RNA market capitalization is higher than 88.29% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +9.76%
    RNA shares outstanding is up +9.76% year-on-year

    Shares Outstanding 3-Year Change

    +131.2%
    RNA shares outstanding is up +131.2% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.18
    RNA beta is 1.18

    200-day SMA

    $33.89
    RNA price is currently +7.02% above its 200-day simple moving average

    50-day SMA

    $31.43
    RNA price is currently +15.38% above its 50-day simple moving average

    RSI

    67.34
    RNA 14-day relative strength index is 67.34

    Volume

    3.01
    RNA 30-day relative volume is 3.01

    ATR

    $2.17
    RNA average true range is $2.17

    10-day Historical Volatility

    71.52%
    RNA 10-day historical volatility is 71.52%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $10.90M
    RNA annual revenue is $10.90 million

    Revenue Analysts estimate

    $7.27M
    RNA annual revenue is currently +49.91% higher than the consensus analysts' forecast

    Revenue 1-year change

    +13.99%
    RNA annual revenue is up +13.99% year-on-year

    Revenue Sector rank

    28.69%
    RNA annual revenue is higher than 28.69% of companies in Healthcare sector

    EPS

    EPS

    -$2.89
    RNA annual earnings per share is -$2.89

    EPS Analysts estimate

    -$3.94
    RNA annual earnings per share is currently -26.73% lower than the consensus analysts' forecast

    EPS 1-year change

    +0.69%
    RNA annual earnings per share is up +0.69% year-on-year

    EPS Sector rank

    31.2%
    RNA annual earnings per share is higher than 31.2% of companies in Healthcare sector

    Profit

    Gross profit

    -
    RNA annual gross profit value is unknown

    Gross margin

    -
    RNA annual gross profit margin value is unknown

    Operating profit

    -$378.94M
    RNA annual operating income is -$378.94 million

    Operating margin

    -3477.43%
    RNA annual operating profit margin is -3477.43%

    Net income

    -$322.30M
    RNA annual net profit is -$322.30 million

    Net margin

    -2957.71%
    RNA annual net profit margin is -2957.71%

    Expenses

    Total expenses

    $389.83M
    RNA annual total expenses is $389.83 million

    Operating expenses

    $389.83M
    RNA annual total operating expenses is $389.83 million

    Cost of goods sold

    -
    RNA annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $86.24M
    RNA annual SGA is $86.24 million

    Depreciation and amortization

    $2.78M
    RNA annual depreciation & amortization is $2.78 million

    Interest expense

    -
    RNA annual interest expense value is unknown

    Income tax

    -
    RNA annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$378.94M
    RNA annual earnings before interest & taxes is -$378.94 million

    EBITDA

    -$376.16M
    RNA annual EBITDA is -$376.16 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.56B
    RNA annual total assets is $1.56 billion

    Non current assets

    $21.61M
    RNA annual long term assets is $21.61 million

    Current assets

    $1.54B
    RNA annual total current assets is $1.54 billion

    Cash and cash equivalents

    $219.87M
    RNA annual cash & cash equivalents is $219.87 million

    Accounts receivable

    $0.00
    RNA annual accounts receivable is $0.00

    Inventory

    -
    RNA annual inventory value is unknown

    Liabilities

    Total liabilities

    $138.94M
    RNA annual total liabilities is $138.94 million

    Long term liabilities

    $40.92M
    RNA annual total long term liabilities is $40.92 million

    Current liabilities

    $98.02M
    RNA annual total current liabilities is $98.02 million

    Accounts payable

    $8.46M
    RNA annual accounts payable is $8.46 million

    Debt

    Total debt

    $6.80M
    RNA annual total debt is $6.80 million

    Total debt 1-year change

    -30.97%
    RNA annual total debt is down -30.97% year-on-year

    Long term debt

    $2.96M
    RNA annual long term debt is $2.96 million

    Short term debt

    $3.84M
    RNA annual short term debt is $3.84 million

    Equity & Capital

    Shareholders equity

    $1.42B
    RNA annual stockholders equity is $1.42 billion

    Book value

    $1.42B
    RNA annual book value is $1.42 billion

    Retained earnings

    -$893.07M
    RNA annual retained earnings is -$893.07 million

    Working capital

    $1.44B
    RNA annual working capital is $1.44 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$300.87M
    RNA annual cash flow from operations is -$300.87 million

    Cash from operations 1-year change

    -152.7%
    RNA annual cash flow from operations is down -152.7% year-on-year

    Cash from investing

    -$854.20M
    RNA annual cash flow from investing activities is -$854.20 million

    Cash from investing 1-year change

    -556.72%
    RNA annual cash flow from investing activities is down -556.72% year-on-year

    Cash from financing

    $1.19B
    RNA annual cash flow from financing activities is $1.19 billion

    Cash from financing 1-year change

    +1170.3%
    RNA annual cash flow from financing activities is up +1170.3% year-on-year

    CAPEX

    CAPEX

    $7.07M
    RNA annual capital expenditures is $7.07 million

    CAPEX 1-year change

    +67.12%
    RNA annual capital expenditures is up +67.12% year-on-year

    Free Cash Flow

    Free cash flow

    -$307.94M
    RNA annual free cash flow is -$307.94 million

    Free cash flow 1-year change

    -149.76%
    RNA annual free cash flow is down -149.76% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    RNA annual gross profit margin value is unknown

    Operating margin

    -3477.43%
    RNA annual operating profit margin is -3477.43%

    Net margin

    -2957.71%
    RNA annual net profit margin is -2957.71%

    ROA & ROE

    ROA

    -29.40%
    RNA annual return on assets is -29.40%

    ROE

    -33.47%
    RNA annual return on equity is -33.47%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    RNA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    RNA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    3.29
    RNA price to book ratio is 3.29

    PB ratio Sector rank

    68.32%
    RNA price to book ratio is higher than 68.32% of companies in Healthcare sector

    PS Ratio

    PS ratio

    489.67
    RNA price to sales ratio is 489.67

    PS ratio Sector rank

    98%
    RNA price to sales ratio is higher than 98% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $4.12B
    RNA enterprise value is $4.12 billion

    Enterprise value Sector rank

    86.41%
    RNA enterprise value is higher than 86.41% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -9.58
    RNA EV/EBITDA is -9.58

    EV/EBITDA Sector rank

    14.88%
    RNA EV/EBITDA is higher than 14.88% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    15.73
    RNA annual current ratio is 15.73

    Quick ratio

    -
    RNA annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    RNA annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    RNA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    RNA piotroski f-score value is unknown

    Altman Z-Score

    18.39
    RNA altman z-score is 18.39

    Analyst ratings

    Recent major analysts updates

    Jun 27, 25 Cantor Fitzgerald
    Overweight
    Jun 17, 25 Wolfe Research
    Outperform
    Jun 11, 25 Raymond James
    Strong Buy
    Jun 10, 25 Citigroup
    Buy
    Jun 10, 25 Barclays
    Overweight
    Jun 9, 25 Chardan Capital
    Buy
    Jun 9, 25 B of A Securities
    Buy
    May 12, 25 HC Wainwright & Co.
    Buy
    May 9, 25 Chardan Capital
    Buy
    May 7, 25 Chardan Capital
    Buy

    Institutional Ownership

    Screeners with RNA included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    • What is the ticker symbol for Avidity Biosciences, Inc.?
    • Does Avidity Biosciences, Inc. pay dividends?
    • What sector is Avidity Biosciences, Inc. in?
    • What industry is Avidity Biosciences, Inc. in?
    • What country is Avidity Biosciences, Inc. based in?
    • When did Avidity Biosciences, Inc. go public?
    • Is Avidity Biosciences, Inc. in the S&P 500?
    • Is Avidity Biosciences, Inc. in the NASDAQ 100?
    • Is Avidity Biosciences, Inc. in the Dow Jones?
    • When was Avidity Biosciences, Inc.'s last earnings report?
    • When does Avidity Biosciences, Inc. report earnings?

    What is the ticker symbol for Avidity Biosciences, Inc.?

    The ticker symbol for Avidity Biosciences, Inc. is NASDAQ:RNA

    Does Avidity Biosciences, Inc. pay dividends?

    No, Avidity Biosciences, Inc. does not pay dividends

    What sector is Avidity Biosciences, Inc. in?

    Avidity Biosciences, Inc. is in the Healthcare sector

    What industry is Avidity Biosciences, Inc. in?

    Avidity Biosciences, Inc. is in the Biotechnology industry

    What country is Avidity Biosciences, Inc. based in?

    Avidity Biosciences, Inc. is headquartered in United States

    When did Avidity Biosciences, Inc. go public?

    Avidity Biosciences, Inc.'s initial public offering (IPO) was on June 12, 2020

    Is Avidity Biosciences, Inc. in the S&P 500?

    No, Avidity Biosciences, Inc. is not included in the S&P 500 index

    Is Avidity Biosciences, Inc. in the NASDAQ 100?

    No, Avidity Biosciences, Inc. is not included in the NASDAQ 100 index

    Is Avidity Biosciences, Inc. in the Dow Jones?

    No, Avidity Biosciences, Inc. is not included in the Dow Jones index

    When was Avidity Biosciences, Inc.'s last earnings report?

    Avidity Biosciences, Inc.'s most recent earnings report was on May 8, 2025

    When does Avidity Biosciences, Inc. report earnings?

    The next expected earnings date for Avidity Biosciences, Inc. is August 8, 2025
    On this page